世界の真性赤血球増加症後骨髄線維症（PPV-MF）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5960 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、真性赤血球増加症後骨髄線維症（PPV-MF）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（デュルバルマブ、ギビノスタット、グラスデギブ、イデラリシブ、IMG-7289、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・真性赤血球増加症後骨髄線維症（PPV-MF）の市場動向 ・企業の競争状況、市場シェア ・真性赤血球増加症後骨髄線維症（PPV-MF）の種類別市場規模と予測2016-2027（デュルバルマブ、ギビノスタット、グラスデギブ、イデラリシブ、IMG-7289、その他） ・真性赤血球増加症後骨髄線維症（PPV-MF）の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・真性赤血球増加症後骨髄線維症（PPV-MF）の北米市場規模2016-2027（アメリカ、カナダ） ・真性赤血球増加症後骨髄線維症（PPV-MF）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・真性赤血球増加症後骨髄線維症（PPV-MF）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・真性赤血球増加症後骨髄線維症（PPV-MF）の中南米市場規模2016-2027（メキシコ、ブラジル） ・真性赤血球増加症後骨髄線維症（PPV-MF）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie Inc、Celgene Corp、CTI BioPharma Corp、F. Hoffmann-La Roche Ltd、Gilead Sciences Inc、Incyte Corp、Italfarmaco SpA、JW Pharmaceutical Corp、MedImmune LLC、MEI Pharma Inc、Merck & Co Inc、Novartis AG、NS Pharma Inc、Promedior Inc、Sun Pharma Advanced Research Company Ltd） ・結論

Market Analysis and Insights: Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market
The global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market.

Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Scope and Market Size
Post-Polycythemia Vera Myelofibrosis (PPV-MF) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Post-Polycythemia Vera Myelofibrosis (PPV-MF) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Durvalumab
Givinostat
Glasdegib
Idelalisib
IMG-7289
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie Inc
Celgene Corp
CTI BioPharma Corp
F. Hoffmann-La Roche Ltd
Gilead Sciences Inc
Incyte Corp
Italfarmaco SpA
JW Pharmaceutical Corp
MedImmune LLC
MEI Pharma Inc
Merck & Co Inc
Novartis AG
NS Pharma Inc
Promedior Inc
Sun Pharma Advanced Research Company Ltd

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Durvalumab
1.2.3 Givinostat
1.2.4 Glasdegib
1.2.5 Idelalisib
1.2.6 IMG-7289
1.2.7 Others
1.3 Market by Application
1.3.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Perspective (2016-2027)
2.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Growth Trends by Regions
2.2.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Historic Market Share by Regions (2016-2021)
2.2.3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecasted Market Size by Regions (2022-2027)
2.3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Industry Dynamic
2.3.1 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Trends
2.3.2 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Drivers
2.3.3 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Challenges
2.3.4 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Post-Polycythemia Vera Myelofibrosis (PPV-MF) Players by Revenue
3.1.1 Global Top Post-Polycythemia Vera Myelofibrosis (PPV-MF) Players by Revenue (2016-2021)
3.1.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share by Players (2016-2021)
3.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue
3.4 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Concentration Ratio
3.4.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in 2020
3.5 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Key Players Head office and Area Served
3.6 Key Players Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Solution and Service
3.7 Date of Enter into Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Breakdown Data by Type
4.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Historic Market Size by Type (2016-2021)
4.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecasted Market Size by Type (2022-2027)

5 Post-Polycythemia Vera Myelofibrosis (PPV-MF) Breakdown Data by Application
5.1 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Historic Market Size by Application (2016-2021)
5.2 Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size (2016-2027)
6.2 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type
6.2.1 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2021)
6.2.2 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2022-2027)
6.2.3 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2027)
6.3 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application
6.3.1 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2021)
6.3.2 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2022-2027)
6.3.3 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2027)
6.4 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country
6.4.1 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2016-2021)
6.4.2 North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size (2016-2027)
7.2 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type
7.2.1 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2021)
7.2.2 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2022-2027)
7.2.3 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2027)
7.3 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application
7.3.1 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2021)
7.3.2 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2022-2027)
7.3.3 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2027)
7.4 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country
7.4.1 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2016-2021)
7.4.2 Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size (2016-2027)
8.2 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type
8.2.1 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2027)
8.3 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application
8.3.1 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2027)
8.4 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Region
8.4.1 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size (2016-2027)
9.2 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type
9.2.1 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2021)
9.2.2 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2022-2027)
9.2.3 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2027)
9.3 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application
9.3.1 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2021)
9.3.2 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2022-2027)
9.3.3 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2027)
9.4 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country
9.4.1 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2016-2021)
9.4.2 Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size (2016-2027)
10.2 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type
10.2.1 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2027)
10.3 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application
10.3.1 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2027)
10.4 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country
10.4.1 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Details
11.1.2 AbbVie Inc Business Overview
11.1.3 AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.1.4 AbbVie Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.1.5 AbbVie Inc Recent Development
11.2 Celgene Corp
11.2.1 Celgene Corp Company Details
11.2.2 Celgene Corp Business Overview
11.2.3 Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.2.4 Celgene Corp Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.2.5 Celgene Corp Recent Development
11.3 CTI BioPharma Corp
11.3.1 CTI BioPharma Corp Company Details
11.3.2 CTI BioPharma Corp Business Overview
11.3.3 CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.3.4 CTI BioPharma Corp Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.3.5 CTI BioPharma Corp Recent Development
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Company Details
11.4.2 F. Hoffmann-La Roche Ltd Business Overview
11.4.3 F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.4.4 F. Hoffmann-La Roche Ltd Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Ltd Recent Development
11.5 Gilead Sciences Inc
11.5.1 Gilead Sciences Inc Company Details
11.5.2 Gilead Sciences Inc Business Overview
11.5.3 Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.5.4 Gilead Sciences Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.5.5 Gilead Sciences Inc Recent Development
11.6 Incyte Corp
11.6.1 Incyte Corp Company Details
11.6.2 Incyte Corp Business Overview
11.6.3 Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.6.4 Incyte Corp Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.6.5 Incyte Corp Recent Development
11.7 Italfarmaco SpA
11.7.1 Italfarmaco SpA Company Details
11.7.2 Italfarmaco SpA Business Overview
11.7.3 Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.7.4 Italfarmaco SpA Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.7.5 Italfarmaco SpA Recent Development
11.8 JW Pharmaceutical Corp
11.8.1 JW Pharmaceutical Corp Company Details
11.8.2 JW Pharmaceutical Corp Business Overview
11.8.3 JW Pharmaceutical Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.8.4 JW Pharmaceutical Corp Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.8.5 JW Pharmaceutical Corp Recent Development
11.9 MedImmune LLC
11.9.1 MedImmune LLC Company Details
11.9.2 MedImmune LLC Business Overview
11.9.3 MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.9.4 MedImmune LLC Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.9.5 MedImmune LLC Recent Development
11.10 MEI Pharma Inc
11.10.1 MEI Pharma Inc Company Details
11.10.2 MEI Pharma Inc Business Overview
11.10.3 MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.10.4 MEI Pharma Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.10.5 MEI Pharma Inc Recent Development
11.11 Merck & Co Inc
11.11.1 Merck & Co Inc Company Details
11.11.2 Merck & Co Inc Business Overview
11.11.3 Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.11.4 Merck & Co Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.11.5 Merck & Co Inc Recent Development
11.12 Novartis AG
11.12.1 Novartis AG Company Details
11.12.2 Novartis AG Business Overview
11.12.3 Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.12.4 Novartis AG Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.12.5 Novartis AG Recent Development
11.13 NS Pharma Inc
11.13.1 NS Pharma Inc Company Details
11.13.2 NS Pharma Inc Business Overview
11.13.3 NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.13.4 NS Pharma Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.13.5 NS Pharma Inc Recent Development
11.14 Promedior Inc
11.14.1 Promedior Inc Company Details
11.14.2 Promedior Inc Business Overview
11.14.3 Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.14.4 Promedior Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.14.5 Promedior Inc Recent Development
11.15 Sun Pharma Advanced Research Company Ltd
11.15.1 Sun Pharma Advanced Research Company Ltd Company Details
11.15.2 Sun Pharma Advanced Research Company Ltd Business Overview
11.15.3 Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Introduction
11.15.4 Sun Pharma Advanced Research Company Ltd Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
11.15.5 Sun Pharma Advanced Research Company Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Durvalumab
Table 3. Key Players of Givinostat
Table 4. Key Players of Glasdegib
Table 5. Key Players of Idelalisib
Table 6. Key Players of IMG-7289
Table 7. Key Players of Others
Table 8. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Regions (2016-2021)
Table 12. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Regions (2022-2027)
Table 14. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Trends
Table 15. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Drivers
Table 16. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Challenges
Table 17. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Restraints
Table 18. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Players (2016-2021)
Table 20. Global Top Post-Polycythemia Vera Myelofibrosis (PPV-MF) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) as of 2020)
Table 21. Ranking of Global Top Post-Polycythemia Vera Myelofibrosis (PPV-MF) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product Solution and Service
Table 25. Date of Enter into Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share by Type (2016-2021)
Table 29. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share by Application (2016-2021)
Table 33. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size by Country (2022-2027) & (US$ Million)
Table 65. AbbVie Inc Company Details
Table 66. AbbVie Inc Business Overview
Table 67. AbbVie Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 68. AbbVie Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 69. AbbVie Inc Recent Development
Table 70. Celgene Corp Company Details
Table 71. Celgene Corp Business Overview
Table 72. Celgene Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 73. Celgene Corp Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 74. Celgene Corp Recent Development
Table 75. CTI BioPharma Corp Company Details
Table 76. CTI BioPharma Corp Business Overview
Table 77. CTI BioPharma Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 78. CTI BioPharma Corp Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 79. CTI BioPharma Corp Recent Development
Table 80. F. Hoffmann-La Roche Ltd Company Details
Table 81. F. Hoffmann-La Roche Ltd Business Overview
Table 82. F. Hoffmann-La Roche Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 83. F. Hoffmann-La Roche Ltd Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 84. F. Hoffmann-La Roche Ltd Recent Development
Table 85. Gilead Sciences Inc Company Details
Table 86. Gilead Sciences Inc Business Overview
Table 87. Gilead Sciences Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 88. Gilead Sciences Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 89. Gilead Sciences Inc Recent Development
Table 90. Incyte Corp Company Details
Table 91. Incyte Corp Business Overview
Table 92. Incyte Corp Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 93. Incyte Corp Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 94. Incyte Corp Recent Development
Table 95. Italfarmaco SpA Company Details
Table 96. Italfarmaco SpA Business Overview
Table 97. Italfarmaco SpA Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 98. Italfarmaco SpA Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 99. Italfarmaco SpA Recent Development
Table 100. JW Pharmaceutical Corp Company Details
Table 101. JW Pharmaceutical Corp Business Overview
Table 102. JW Pharmaceutical Corp Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 103. JW Pharmaceutical Corp Recent Development
Table 104. MedImmune LLC Company Details
Table 105. MedImmune LLC Business Overview
Table 106. MedImmune LLC Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 107. MedImmune LLC Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 108. MedImmune LLC Recent Development
Table 109. MEI Pharma Inc Company Details
Table 110. MEI Pharma Inc Business Overview
Table 111. MEI Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 112. MEI Pharma Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 113. MEI Pharma Inc Recent Development
Table 114. Merck & Co Inc Company Details
Table 115. Merck & Co Inc Business Overview
Table 116. Merck & Co Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 117. Merck & Co Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 118. Merck & Co Inc Recent Development
Table 119. Novartis AG Company Details
Table 120. Novartis AG Business Overview
Table 121. Novartis AG Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 122. Novartis AG Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 123. Novartis AG Recent Development
Table 124. NS Pharma Inc Company Details
Table 125. NS Pharma Inc Business Overview
Table 126. NS Pharma Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 127. NS Pharma Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 128. NS Pharma Inc Recent Development
Table 129. Promedior Inc Company Details
Table 130. Promedior Inc Business Overview
Table 131. Promedior Inc Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 132. Promedior Inc Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 133. Promedior Inc Recent Development
Table 134. Sun Pharma Advanced Research Company Ltd Company Details
Table 135. Sun Pharma Advanced Research Company Ltd Business Overview
Table 136. Sun Pharma Advanced Research Company Ltd Post-Polycythemia Vera Myelofibrosis (PPV-MF) Product
Table 137. Sun Pharma Advanced Research Company Ltd Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021) & (US$ Million)
Table 138. Sun Pharma Advanced Research Company Ltd Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Type: 2020 VS 2027
Figure 2. Durvalumab Features
Figure 3. Givinostat Features
Figure 4. Glasdegib Features
Figure 5. Idelalisib Features
Figure 6. IMG-7289 Features
Figure 7. Others Features
Figure 8. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Report Years Considered
Figure 13. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Regions: 2020 VS 2027
Figure 16. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Regions (2022-2027)
Figure 17. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Players in 2020
Figure 18. Global Top Post-Polycythemia Vera Myelofibrosis (PPV-MF) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Post-Polycythemia Vera Myelofibrosis (PPV-MF) as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue in 2020
Figure 20. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share by Type (2016-2021)
Figure 21. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Revenue Market Share by Type (2022-2027)
Figure 22. North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Type (2016-2027)
Figure 24. North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Application (2016-2027)
Figure 25. North America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Country (2016-2027)
Figure 26. United States Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Type (2016-2027)
Figure 30. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Application (2016-2027)
Figure 31. Europe Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Country (2016-2027)
Figure 32. Germany Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Region (2016-2027)
Figure 42. China Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Type (2016-2027)
Figure 50. Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Application (2016-2027)
Figure 51. Latin America Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Country (2016-2027)
Figure 52. Mexico Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Share by Country (2016-2027)
Figure 58. Turkey Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Post-Polycythemia Vera Myelofibrosis (PPV-MF) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AbbVie Inc Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 62. Celgene Corp Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 63. CTI BioPharma Corp Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 64. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 65. Gilead Sciences Inc Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 66. Incyte Corp Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 67. Italfarmaco SpA Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 68. JW Pharmaceutical Corp Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 69. MedImmune LLC Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 70. MEI Pharma Inc Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 71. Merck & Co Inc Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 72. Novartis AG Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 73. NS Pharma Inc Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 74. Promedior Inc Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 75. Sun Pharma Advanced Research Company Ltd Revenue Growth Rate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

---